Morphine Withdrawn Phase 2 Trials for Pain, Chronic Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00943566A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer